These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 16415090)

  • 41. Modeling cyclosporine A inhibition of the distribution of a P-glycoprotein PET ligand, 11C-verapamil, into the maternal brain and fetal liver of the pregnant nonhuman primate: impact of tissue blood flow and site of inhibition.
    Ke AB; Eyal S; Chung FS; Link JM; Mankoff DA; Muzi M; Unadkat JD
    J Nucl Med; 2013 Mar; 54(3):437-46. PubMed ID: 23359659
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Limited interaction between tacrolimus and P-glycoprotein in the rat small intestine.
    Saitoh H; Saikachi Y; Kobayashi M; Yamaguchi M; Oda M; Yuhki Y; Achiwa K; Tadano K; Takahashi Y; Aungst BJ
    Eur J Pharm Sci; 2006 May; 28(1-2):34-42. PubMed ID: 16457995
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Blood-brain barrier transport of H1-antagonist ebastine and its metabolite carebastine.
    Tamai I; Kido Y; Yamashita J; Sai Y; Tsuji A
    J Drug Target; 2000; 8(6):383-93. PubMed ID: 11328664
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A simplified protocol employing elacridar in rodents: a screening model in drug discovery to assess P-gp mediated efflux at the blood brain barrier.
    Kallem R; Kulkarni CP; Patel D; Thakur M; Sinz M; Singh SP; Mahammad SS; Mandlekar S
    Drug Metab Lett; 2012 Jun; 6(2):134-44. PubMed ID: 23061481
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A kinetic evaluation of the absorption, efflux, and metabolism of verapamil in the autoperfused rat jejunum.
    Johnson BM; Chen W; Borchardt RT; Charman WN; Porter CJ
    J Pharmacol Exp Ther; 2003 Apr; 305(1):151-8. PubMed ID: 12649363
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of the permeation characteristics of a model opioid peptide, H-Tyr-D-Ala-Gly-Phe-D-Leu-OH (DADLE), and its cyclic prodrugs across the blood-brain barrier using an in situ perfused rat brain model.
    Chen W; Yang JZ; Andersen R; Nielsen LH; Borchardt RT
    J Pharmacol Exp Ther; 2002 Nov; 303(2):849-57. PubMed ID: 12388672
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of lovastatin on the pharmacokinetics of verapamil and its active metabolite, norverapamil in rats: possible role of P-glycoprotein inhibition by lovastatin.
    Hong SP; Chang KS; Koh YY; Choi DH; Choi JS
    Arch Pharm Res; 2009 Oct; 32(10):1447-52. PubMed ID: 19898809
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Blood-brain barrier cell line PBMEC/C1-2 possesses functionally active P-glycoprotein.
    Neuhaus W; Stessl M; Strizsik E; Bennani-Baiti B; Wirth M; Toegel S; Modha M; Winkler J; Gabor F; Viernstein H; Noe CR
    Neurosci Lett; 2010 Jan; 469(2):224-8. PubMed ID: 19963040
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Transport of amentoflavone across the blood-brain barrier in vitro.
    Gutmann H; Bruggisser R; Schaffner W; Bogman K; Botomino A; Drewe J
    Planta Med; 2002 Sep; 68(9):804-7. PubMed ID: 12357391
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Potentiation of domperidone-induced catalepsy by a P-glycoprotein inhibitor, cyclosporin A.
    Tsujikawa K; Dan Y; Nogawa K; Sato H; Yamada Y; Murakami H; Ohtani H; Sawada Y; Iga T
    Biopharm Drug Dispos; 2003 Apr; 24(3):105-14. PubMed ID: 12673668
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vivo blood-brain barrier transport of oxycodone in the rat: indications for active influx and implications for pharmacokinetics/pharmacodynamics.
    Boström E; Simonsson US; Hammarlund-Udenaes M
    Drug Metab Dispos; 2006 Sep; 34(9):1624-31. PubMed ID: 16763013
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Functional characterization of the brain-to-blood efflux clearance of human amyloid-beta peptide (1-40) across the rat blood-brain barrier.
    Ito S; Ohtsuki S; Terasaki T
    Neurosci Res; 2006 Nov; 56(3):246-52. PubMed ID: 16926058
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The pronociceptive effect of ondansetron in the setting of P-glycoprotein inhibition.
    Scott JA; Wood M; Flood P
    Anesth Analg; 2006 Sep; 103(3):742-6. PubMed ID: 16931690
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Influence of Verapamil and Cyclosporin A on bile acid metabolism and transport in rat liver slices.
    Barth A; Braun J; Müller D
    Exp Toxicol Pathol; 2006 Aug; 58(1):31-7. PubMed ID: 16793245
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The influence of enaminones on the transport and oral bioavailability of P-glycoprotein substrate therapeutic agents.
    Salama NN; Scott KR; Eddington ND
    Int J Pharm; 2004 Apr; 273(1-2):135-47. PubMed ID: 15010138
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Possible involvement of cationic-drug sensitive transport systems in the blood-to-brain influx and brain-to-blood efflux of amantadine across the blood-brain barrier.
    Suzuki T; Fukami T; Tomono K
    Biopharm Drug Dispos; 2015 Mar; 36(2):126-37. PubMed ID: 25410756
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of P-170 glycoprotein in colchicine brain uptake.
    Drion N; Risede P; Cholet N; Chanez C; Scherrmann JM
    J Neurosci Res; 1997 Jul; 49(1):80-8. PubMed ID: 9211992
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In-vivo and in-vitro studies on the effect of Huang-Lian-Jie-Du-Tang on nimodipine transport across rat blood-brain barrier.
    Zhang DM; He ZW; Liu XD; Li Y; Xie L; Wang GJ; Liu L
    J Pharm Pharmacol; 2007 Dec; 59(12):1733-8. PubMed ID: 18053337
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Blood-brain barrier in vitro models as tools in drug discovery: assessment of the transport ranking of antihistaminic drugs.
    Neuhaus W; Mandikova J; Pawlowitsch R; Linz B; Bennani-Baiti B; Lauer R; Lachmann B; Noe CR
    Pharmazie; 2012 May; 67(5):432-9. PubMed ID: 22764578
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Administration of drugs known to inhibit P-glycoprotein increases brain bilirubin and alters the regional distribution of bilirubin in rat brain.
    Hankø E; Tommarello S; Watchko JF; Hansen TW
    Pediatr Res; 2003 Oct; 54(4):441-5. PubMed ID: 12904601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.